Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2008
11/27/2008US20080293627 Thyrotropin Receptor Preparations, Binding Regions Thereof, Antibody and Hormone Interactions Therewith, and Uses Thereof
11/27/2008US20080293162 Methods and compositions for diagnosing neoplastic disease
11/27/2008US20080293141 Cell for Producing Retrovirus Vector
11/27/2008US20080293140 Cultured in the presence of a compound which selectively inhibits propagation or survival of cells other than ES cells; cell-free
11/27/2008US20080293139 Cell culture support for forming string-shaped cardiomyocyte aggregates
11/27/2008US20080293138 Biologically active substance transfer sheet, cell culture kit constituted of cell culture plate and biologically active substance transfer sheet, producing method thereof and method for screening cell culture conditions utilizing the same
11/27/2008US20080293137 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments
11/27/2008US20080293135 Co-Culture Bioreactor System
11/27/2008US20080293133 Textiles for use in bioreactors for expansion and maintenance of cells
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
11/27/2008US20080293099 Lignan Glycosidase and Utilization of the Same
11/27/2008US20080293087 Sulfonylurea receptor short forms from mitochondria and uses thereof
11/27/2008US20080293077 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
11/27/2008US20080293076 Method to improve barrier function of cell-cell junctions
11/27/2008US20080293070 Markers for Memory T Cells and Uses Thereof
11/27/2008US20080293056 Method for preparing cancer stem cells
11/27/2008US20080293046 RNA detection assays
11/27/2008US20080293044 Melks as Modifiers of the Rac Pathway and Methods of Use
11/27/2008US20080293036 Monoclonal Antibodies to Hiv-1 and Methods of Using Same
11/27/2008US20080292735 Regulating alkaloids
11/27/2008US20080292709 Kits for dhea and dhea-sulfate for the treatment of chronic obstructive pulmonary disease
11/27/2008US20080292704 Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins
11/27/2008US20080292677 Engineered lung tissue, hydrogel/somatic lung progenitor cell constructs to support tissue growth, and method for making and using same
11/27/2008US20080292667 Nonwoven Nanofibrous Membranes of Silk Fibroin for Guided Bone Tissue Regeneration and Their Preparation Method
11/27/2008US20080292658 Defective Influenza Virus Particles
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292653 Live attenuated antigenically marked classical swine fever virus
11/27/2008US20080292649 Composition for improving membrane composition and functioning of cells
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292646 Recombinant fusion protein and polynucleotide construct for immunotoxin production
11/27/2008US20080292643 Leukocyte inactivation module
11/27/2008US20080292641 Antigenic GM-CSF peptides and antibodies to GM-CSF
11/27/2008US20080292639 Humanized Anti-Amyloid Antibody
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
11/27/2008US20080292633 Compositions and methods for the therapy and diagnosis of lung cancer
11/27/2008US20080292632 Irta2 Antibodies and Methods of Use
11/27/2008US20080292629 System Clock Generation Circuit
11/27/2008US20080292628 Chimeric Protein
11/27/2008US20080292627 Compositions and Methods for Treating Mood and Anxiety Disorders
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292623 Mammalian cell membrane proteins; related reagents
11/27/2008US20080292620 PRLR-Specific Antibody and Uses Thereof
11/27/2008US20080292617 Antibody against a peptide derived from human mutant lamin a protein and uses thereof
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292605 Materials for stimulation of hematopoiesis by ex vivo activated cells
11/27/2008US20080292602 T Cell Receptors Which Specifically Bind to Vygfvracl-Hla-A24
11/27/2008US20080292601 Treatment of graft-versus-host disease with il-10 expressing cells
11/27/2008US20080292600 Treatment of graft-versus-host disease
11/27/2008US20080292599 Pluripotent mesenchymal cells artificially enhanced with a LIM mineralization protein fragment necessary for osteoinduction; joint and disk diseases; increased chondrogenic marker expression
11/27/2008US20080292581 Interleukin-11 Fusion Proteins
11/27/2008US20080292549 High Affinity Melan-A T Cell Receptors
11/27/2008US20080292546 Compositions and methods for treating and diagnosing cancer
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008US20080290050 Device, Kit to Filter Bone Marrow Aspirate
11/27/2008US20080289252 Methods of Using Transformed Plants Expressing Plant-Derived Acyl-CoEnzyme-A-Binding Proteins in Phytoremediation
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008CA2687637A1 Partially degradable scaffolds for biomedical applications
11/27/2008CA2687534A1 Method for production of dendritic cell
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687493A1 Recombinant protein production in avian ebx r cells
11/27/2008CA2681480A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/26/2008EP1995321A2 Gene disruptions, compositions and methods relating thereto
11/26/2008EP1995318A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995317A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995309A1 Recombinant protein production in avian EBx® cells
11/26/2008EP1995255A1 Truncated tau proteins
11/26/2008EP1994949A1 Scaffold material
11/26/2008EP1994942A1 Pharmaceutical compositions comprising telomerase, and uses thereof
11/26/2008EP1994824A1 Chimeric non-human animal
11/26/2008EP1994178A2 Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
11/26/2008EP1994156A1 Chimeric tymovirus-like particles
11/26/2008EP1994146A1 Cancerous disease modifying antibody 141205-02
11/26/2008EP1994145A2 Production of biologically active proteins
11/26/2008EP1994144A1 Human embryonic stem cell methods and podxl expression
11/26/2008EP1994143A2 Method and apparatus for maintenance and expansion of hematopoietic stem cells from mononuclear cells
11/26/2008EP1994141A2 Compositions and methods useful for culturing differentiable cells
11/26/2008EP1994140A2 Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture
11/26/2008EP1993603A1 Hepatitis c virus non structural fusion protein
11/26/2008EP1993597A2 Human telomerase reverse transcriptase peptides
11/26/2008EP1993575A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
11/26/2008EP1993574A2 Specific cd4+cd25+ regulatory t cells for haematopoietic cell transplantation and immune tolerance
11/26/2008EP1993562A2 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling
11/26/2008EP1993349A2 Soybean seed and oil compositions and methods of making same
11/26/2008EP1863334A4 Drought-resistant plants
11/26/2008EP1838844A4 Differentiation of human embryonic stem cells and cardiomyocytes and cardiomyocyte progenitors derived therefrom
11/26/2008EP1658365B1 Method for recloning production cells
11/26/2008EP1515752B1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/26/2008EP1493035B1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell
11/26/2008EP1434592B1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
11/26/2008EP1104231B1 Biodegradable high oxidative stability oils
11/26/2008EP1019537B1 Bioassay for thyroid stimulating antibodies
11/26/2008EP0821732B1 Altered polypeptides with increased half-life
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008CN101313069A Bioassays
11/26/2008CN101313064A 基因扩增方法 Gene amplification method
11/26/2008CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
11/26/2008CN101313062A Cell populations having immunoregulatory activity, method for isolation and uses
11/26/2008CN101313061A Method of expanding double negative t cells
11/26/2008CN101312989A Monoclonal antibodies against claudin-18 for treatment of cancer
1 ... 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 ... 1827